Non-Oncology Biopharmaceuticals Market to hit US$ 313.70B by 2033, driven by rising demand for biologics, biosimilars & gene therapies for rare diseases. Non-Oncology Biopharmaceuticals Market to hit ...

Establish Point-of-Care (PoC) CAR-T centers across India using automated manufacturing platforms such as Miltenyi’s CliniMACS Prodigy system, enabling cost-effective and scalable access to ...

Xie Zhen's team from Tsinghua University published a research article titled "SPECIFIC: A systematic framework for ...

GeneCentric Announces $8 Million Series C Financing to Advance Novel GenomicsNext Liquid Biopsy Platform for Precision Oncology ...

Verve Therapeutics remains an early-stage biotech, making the rally purely acquisition-driven, not based on fundamentals.

Our Bureau, Mumbai Wednesday, June 18, 2025, 16:30 Hrs [IST] ...

For his DC-PGE project (DNA-binding domain Conditioned Precision Genome Editing), Prof. Frank Buchholz has been awarded an Advanced Grant from the European Research Council (ERC), the highest endowed ...

Ocugen, Inc. (NASDAQ: OCGN) has received clearance from the U.S. Food and Drug Administration (FDA) to begin a Phase 2/3 ...

FDA unveils a priority voucher program to accelerate drug reviews for national priorities, using a team-based review model.

Aldeyra has resubmitted its new drug application for reproxalap, an investigational dry eye treatment, which contained new ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...